Abbott Receives U.S. FDA Approval for AndroGel® 1.62% to Treat Men with Low...
New, Low-Volume Formulation to Help Restore Low Testosterone Levels in Men ABBOTT PARK, Ill., April 29, 2011 (CRWENewswire)– Abbott (NYSE:ABT) announced today that the U.S. Food and Drug Administration...
View ArticleAUTH, ABT, GEVO, ORFG, CX, GRHU – Afternoon Stock Market Highlights Plus 2...
AuthenTec (NASDAQ:AUTH), a leading provider of security and identity management solutions, reported that it will report its first quarter 2011 financial results for the period ending April 1, 2011 on...
View Article
More Pages to Explore .....
